Cargando…

Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis

PURPOSE: It is difficult to make a clear differential diagnosis of pancreatic carcinoma (PC) and mass-forming chronic pancreatitis (MFCP) via conventional examinations. We aimed to develop a novel model incorporating an MRI-based radiomics signature with clinical biomarkers for distinguishing the tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jingjing, Hu, Lei, Zhou, Bi, Wu, Chungen, Cheng, Yingsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818577/ https://www.ncbi.nlm.nih.gov/pubmed/35114568 http://dx.doi.org/10.1016/j.tranon.2022.101357

Ejemplares similares

Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head
por: Ruan, Zhibing, et al.
Publicado: (2018)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions
por: Deng, Yan, et al.
Publicado: (2021)

Clinical Value of Mean Platelet Volume to Platelet Ratio (MPR) in Distinguishing Mass-Forming Chronic Pancreatitis and Pancreatic Cancer
por: Wang, Han-Xuan, et al.
Publicado: (2023)

Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis
por: Ye, Yingjian, et al.
Publicado: (2023)

Are radiomic signatures ready for incorporation in the clinical pipeline?
por: Singh, Apurva, et al.
Publicado: (2023)

Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass
por: Chhatriya, Bishnupriya, et al.
Publicado: (2020)

Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)
por: Li, Yecheng, et al.
Publicado: (2021)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Radiomic features from MRI distinguish myxomas from myxofibrosarcomas
por: Martin-Carreras, Teresa, et al.
Publicado: (2019)

Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses
por: Li, Yan, et al.
Publicado: (2021)

Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma
por: Ren, Shuai, et al.
Publicado: (2020)

Radiomics approach to distinguish between well differentiated liposarcomas and lipomas on MRI
por: Vos, M., et al.
Publicado: (2019)

MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
por: Ming, Xue, et al.
Publicado: (2019)

Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
por: Vrba, Lukas, et al.
Publicado: (2022)

A Focal Mass-Forming Autoimmune Pancreatitis Mimicking Pancreatic Cancer with Obstruction of the Main Pancreatic Duct
por: Matsumoto, Ippei, et al.
Publicado: (2011)

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice
por: Kishimoto, Shun, et al.
Publicado: (2019)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Radiomics analysis of contrast-enhanced T1W MRI: predicting the recurrence of acute pancreatitis
por: Tang, Lingling, et al.
Publicado: (2023)

Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging
por: Zhang, Ting-Ting, et al.
Publicado: (2016)

4532 Pancreatic Cyst Risk Stratification for Early Detection of Pancreatic Cancer Using Quantitative Radiomics and Activity-Based Biomarkers
por: Hernandez, Sophia, et al.
Publicado: (2020)

Mass forming chronic pancreatitis mimicking pancreatic cystic neoplasm: A case report
por: Jee, Keum Nahn
Publicado: (2018)

Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation
por: Schima, Wolfgang, et al.
Publicado: (2020)

Spectral CT-based radiomics signature for distinguishing malignant pulmonary nodules from benign
por: Xu, Hang, et al.
Publicado: (2023)

Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection
por: van der Kroft, Gregory, et al.
Publicado: (2023)

Mass-forming Pancreatitis with a Duct-penetrating Sign
por: Tufanoğlu, Fatih Hakan, et al.
Publicado: (2023)

Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Publicado: (2018)

Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images
por: Ren, Shuai, et al.
Publicado: (2019)

Can Serum ICAM 1 distinguish pancreatic cancer from chronic pancreatitis?
por: Mohamed, Amal, et al.
Publicado: (2016)

An Incidental Pancreatic Finding at 18F-Choline PET/CT: Chronic Mass-Forming Pancreatitis
por: Evangelista, Laura, et al.
Publicado: (2021)

Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics—A Review
por: Amaral, Maria João, et al.
Publicado: (2023)

Radiomics for the Diagnosis and Differentiation of Pancreatic Cystic Lesions
por: Machicado, Jorge D., et al.
Publicado: (2020)

The impact of radiomics in diagnosis and staging of pancreatic cancer
por: Casà, Calogero, et al.
Publicado: (2022)

Advancements of molecular imaging and radiomics in pancreatic carcinoma
por: Pang, Xiao-Xi, et al.
Publicado: (2023)

Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
por: Wu, Shaoxu, et al.
Publicado: (2018)

Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer
por: Wang, Shihui, et al.
Publicado: (2022)

An Ultrasonic-Based Radiomics Nomogram for Distinguishing Between Benign and Malignant Solid Renal Masses
por: Li, Chunxiang, et al.
Publicado: (2022)

Mass-Forming Chronic Pancreatitis: Diagnostic Performance of PET/CT
por: Reddy, Ravikanth
Publicado: (2022)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5r6hj4r0jac5q8bg69569j38f3